Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 385

1.

Novel PDGFRB rearrangement in multifocal infantile myofibromatosis is tumorigenic and sensitive to imatinib.

Hassan M, Butler E, Wilson R, Roy A, Zheng Y, Liem P, Rakheja D, Pavlick D, Young LL, Rosenzweig M, Erlich R, Ali SM, Leavey PJ, Parsons DW, Skapek SX, Laetsch TW.

Cold Spring Harb Mol Case Stud. 2019 Oct 23;5(5). pii: a004440. doi: 10.1101/mcs.a004440. Print 2019 Oct.

2.

Mentorship for Nurse Scientists: Strategies for Growth From the Oncology Nursing Society Research Mentorship Task Force.

Rosenzweig MQ, Bailey DE, Bush NJ, Coombs LA, Lehto RH, Loerzel V, Sun V, Mooney K, Cooley ME.

Oncol Nurs Forum. 2019 Nov 1;46(6):769-774. doi: 10.1188/19.ONF.769-774.

PMID:
31626617
3.

Symptom Experience, Management, and Outcomes According to Race and Social Determinants Including Genomics, Epigenomics, and Metabolomics (SEMOARS + GEM): an Explanatory Model for Breast Cancer Treatment Disparity.

McCall MK, Connolly M, Nugent B, Conley YP, Bender CM, Rosenzweig MQ.

J Cancer Educ. 2019 Aug 8. doi: 10.1007/s13187-019-01571-w. [Epub ahead of print]

PMID:
31392599
4.

Individual willingness to leave a safe refuge and the trade-off between food and safety: a test with social fish.

Balaban-Feld J, Mitchell WA, Kotler BP, Vijayan S, Tov Elem LT, Rosenzweig ML, Abramsky Z.

Proc Biol Sci. 2019 Jul 24;286(1907):20190826. doi: 10.1098/rspb.2019.0826. Epub 2019 Jul 17.

PMID:
31311474
5.

Understanding the Role of Advanced Practice Providers in Oncology in the United States.

Bruinooge SS, Pickard TA, Vogel W, Hanley A, Schenkel C, Garrett-Mayer E, Tetzlaff E, Rosenzweig M, Hylton H, Westin SN, Smith N, Lynch C, Kosty MP, Williams SF.

J Adv Pract Oncol. 2018 Sep-Oct;9(6):585-598. Epub 2018 Sep 1. Review.

6.

Time to revisit? A predator's previous successes and failures in prey capture determine its return time to patches.

Vijayan S, Lee JK, Balaban-Feld J, Mitchell WA, Kotler BP, Rosenzweig ML, Lotan TT, Abramsky Z.

Oecologia. 2019 Jun;190(2):387-397. doi: 10.1007/s00442-019-04425-w. Epub 2019 May 30.

PMID:
31147778
7.

The Impact of Age and Adjuvant Chemotherapy Modifications on Survival Among Black Women With Breast Cancer.

Nugent BD, Ren D, Bender CM, Rosenzweig M.

Clin Breast Cancer. 2019 Aug;19(4):254-258. doi: 10.1016/j.clbc.2019.02.012. Epub 2019 Mar 7.

PMID:
31000399
8.

The Support, Education, and Advocacy (SEA) Program of Care for Women With Metastatic Breast Cancer: A Nurse-Led Palliative Care Demonstration Program.

Reiser V, Rosenzweig M, Welsh A, Ren D, Usher B.

Am J Hosp Palliat Care. 2019 Oct;36(10):864-870. doi: 10.1177/1049909119839696. Epub 2019 Apr 11.

PMID:
30974954
9.

A complete series of uranium(iv) complexes with terminal hydrochalcogenido (EH) and chalcogenido (E) ligands E = O, S, Se, Te.

Rosenzweig MW, Hümmer J, Scheurer A, Lamsfus CA, Heinemann FW, Maron L, Mazzanti M, Meyer K.

Dalton Trans. 2019 Aug 7;48(29):10853-10864. doi: 10.1039/c9dt00530g. Epub 2019 Apr 5.

PMID:
30950469
10.

Leflunomide regulates c-Myc expression in myeloma cells through PIM targeting.

Buettner R, Morales C, Caserta E, Troadec E, Gunes EG, Viola D, Khalife J, Li H, Keats JJ, Christofferson A, Wu X, Synold TW, Palmer J, Sanchez JF, Pozhitkov A, Vaidehi N, Marcucci G, Krishnan A, Rosenzweig MA, Pichiorri F, Rosen ST.

Blood Adv. 2019 Apr 9;3(7):1027-1032. doi: 10.1182/bloodadvances.2018027227. No abstract available.

11.

Psychosocial Experiences of Young Adults Diagnosed With Acute Leukemia During Hospitalization for Induction Chemotherapy Treatment.

Albrecht TA, Keim-Malpass J, Boyiadzis M, Rosenzweig M.

J Hosp Palliat Nurs. 2019 Apr;21(2):167-173. doi: 10.1097/NJH.0000000000000545.

PMID:
30829935
12.

Improving Knowledge, Comfort, and Confidence of Nurses Providing End-of-Life Care in the Hospital Setting Through Use of the CARES Tools.

Stacy A, Magdic K, Rosenzweig M, Freeman B, Verosky D.

J Hosp Palliat Nurs. 2019 Jun;21(3):200-206. doi: 10.1097/NJH.0000000000000510.

PMID:
30829826
13.

Features Associated With Long-Term Survival in Patients With Metastatic Breast Cancer.

Klar N, Rosenzweig M, Diergaarde B, Brufsky A.

Clin Breast Cancer. 2019 Aug;19(4):304-310. doi: 10.1016/j.clbc.2019.01.014. Epub 2019 Feb 6.

PMID:
30827763
14.

IGLOSS: iterative gapless local similarity search.

Rabar B, Zagorščak M, Ristov S, Rosenzweig M, Goldstein P.

Bioinformatics. 2019 Sep 15;35(18):3491-3492. doi: 10.1093/bioinformatics/btz086.

PMID:
30721953
15.

Nurses' perspectives on the personal and professional impact of providing nurse-led primary palliative care in outpatient oncology settings.

Feldenzer K, Rosenzweig M, Soodalter JA, Schenker Y.

Int J Palliat Nurs. 2019 Jan 2;25(1):30-37. doi: 10.12968/ijpn.2019.25.1.30.

16.

Oncology Nurse Practitioner Web Education Resource(ONc-PoWER): An Evaluation of a Web-Enhanced Education Resource for Nurse Practitioners Who Are New to Cancer Care.

Hoffmann RL, Klein S, Connolly M, Rosenzweig MQ.

J Adv Pract Oncol. 2018 Jan-Feb;9(1):27-37. Epub 2018 Jan 1. Review.

17.

Financial Toxicity Among Women With Metastatic Breast Cancer.

Rosenzweig M, West M, Matthews J, Stokan M, Yoojin Kook YK, Gallups S, Diergaarde B.

Oncol Nurs Forum. 2019 Jan 13;46(1):83-91. doi: 10.1188/19.ONF.83-91.

18.

Understanding the role of advanced practice providers in oncology in the United States.

Bruinooge SS, Pickard TA, Vogel W, Hanley A, Schenkel C, Garrett-Mayer E, Tetzlaff E, Rosenzweig M, Hylton H, Westin SN, Smith N, Lynch C, Kosty MP, Williams SF.

JAAPA. 2018 Dec;31(12):1-12. doi: 10.1097/01.JAA.0000549592.10756.4a. Review.

PMID:
30489397
19.

Understanding the Role of Advanced Practice Providers in Oncology in the United States.

Bruinooge S, Pickard TA, Vogel W, Hanley A, Schenkel C, Garrett-Mayer E, Tetzlaff E, Rosenzweig M, Hylton H, Westin SN, Smith N, Lynch C, Kosty MP, Williams SF.

Oncol Nurs Forum. 2018 Nov 1;45(6):786-800. doi: 10.1188/18.ONF.786-800.

PMID:
30339144
20.

Daratumumab induces CD38 internalization and impairs myeloma cell adhesion.

Ghose J, Viola D, Terrazas C, Caserta E, Troadec E, Khalife J, Gunes EG, Sanchez J, McDonald T, Marcucci G, Kaur B, Rosenzweig M, Keats J, Rosen S, Krishnan A, Satoskar AR, Hofmeister CC, Pichiorri F.

Oncoimmunology. 2018 Jul 23;7(10):e1486948. doi: 10.1080/2162402X.2018.1486948. eCollection 2018.

21.

Predictors of Adherence and Treatment Delays among African American Women Recommended to Receive Breast Cancer Chemotherapy.

Gallups SF, Connolly MC, Bender CM, Rosenzweig MQ.

Womens Health Issues. 2018 Nov - Dec;28(6):553-558. doi: 10.1016/j.whi.2018.08.001. Epub 2018 Sep 18.

PMID:
30241793
22.

Symptom Map of Endocrine Therapy for Breast Cancer: A Scoping Review.

Zhu Y, Cohen SM, Rosenzweig MQ, Bender CM.

Cancer Nurs. 2019 Sep/Oct;42(5):E19-E30. doi: 10.1097/NCC.0000000000000632.

PMID:
30138143
23.

Understanding the Role of Advanced Practice Providers in Oncology in the United States.

Bruinooge SS, Pickard TA, Vogel W, Hanley A, Schenkel C, Garrett-Mayer E, Tetzlaff E, Rosenzweig M, Hylton H, Westin SN, Smith N, Lynch C, Kosty MP, Williams SF.

J Oncol Pract. 2018 Sep;14(9):e518-e532. doi: 10.1200/JOP.18.00181. Epub 2018 Aug 22. Erratum in: J Oncol Pract. 2019 Jan;15(1):60.

PMID:
30133346
24.

An Automated Intervention Did Not Improve Adherence to Oral Oncolytic Agents While Managing Symptoms: Results From a Two-Arm Randomized Controlled Trial.

Sikorskii A, Given CW, Given BA, Vachon E, Krauss JC, Rosenzweig M, McCorkle R, Champion VL, Banik A, Majumder A.

J Pain Symptom Manage. 2018 Nov;56(5):727-735. doi: 10.1016/j.jpainsymman.2018.07.021. Epub 2018 Aug 8.

PMID:
30096441
25.

Exploring Racial Differences in Patient Centeredness of Care (PCC) During Breast Cancer (BC) Chemotherapy Clinical Visits.

Robertson-Jones TA, Tissue MM, Connolly M, Gallups SF, Bender CM, Rosenzweig MQ.

J Racial Ethn Health Disparities. 2019 Feb;6(1):94-100. doi: 10.1007/s40615-018-0503-0. Epub 2018 Jul 3.

PMID:
29971577
26.

Interventionist training and intervention fidelity monitoring and maintenance for CONNECT, a nurse-led primary palliative care in oncology trial.

Robbins-Welty GA, Mueser L, Mitchell C, Pope N, Arnold R, Park S, White D, Smith KJ, Reynolds C, Rosenzweig M, Bakitas M, Schenker Y.

Contemp Clin Trials Commun. 2018 Mar 15;10:57-61. doi: 10.1016/j.conctc.2018.03.006. eCollection 2018 Jun.

27.

Trajectories of Cognitive Function and Associated Phenotypic and Genotypic Factors in Breast Cancer.

Bender CM, Merriman JD, Sereika SM, Gentry AL, Casillo FE, Koleck TA, Rosenzweig MQ, Brufsky AM, McAuliffe P, Zhu Y, Conley YP.

Oncol Nurs Forum. 2018 May 1;45(3):308-326. doi: 10.1188/18.ONF.308-326.

28.

Atypical Presentation of Gelsolin Amyloidosis in a Man of African Descent with a Novel Mutation in the Gelsolin Gene.

Oregel KZ, Shouse GP, Oster C, Martinez F, Wang J, Rosenzweig M, Deisch JK, Chen CS, Nagaraj G.

Am J Case Rep. 2018 Mar 30;19:374-381.

29.

Randomised clinical trial of an early palliative care intervention (SUPPORT) for patients with idiopathic pulmonary fibrosis (IPF) and their caregivers: protocol and key design considerations.

Lindell KO, Nouraie M, Klesen MJ, Klein S, Gibson KF, Kass DJ, Rosenzweig MQ.

BMJ Open Respir Res. 2018 Feb 19;5(1):e000272. doi: 10.1136/bmjresp-2017-000272. eCollection 2018.

30.

Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer.

Hartmaier RJ, Trabucco SE, Priedigkeit N, Chung JH, Parachoniak CA, Vanden Borre P, Morley S, Rosenzweig M, Gay LM, Goldberg ME, Suh J, Ali SM, Ross J, Leyland-Jones B, Young B, Williams C, Park B, Tsai M, Haley B, Peguero J, Callahan RD, Sachelarie I, Cho J, Atkinson JM, Bahreini A, Nagle AM, Puhalla SL, Watters RJ, Erdogan-Yildirim Z, Cao L, Oesterreich S, Mathew A, Lucas PC, Davidson NE, Brufsky AM, Frampton GM, Stephens PJ, Chmielecki J, Lee AV.

Ann Oncol. 2018 Apr 1;29(4):872-880. doi: 10.1093/annonc/mdy025.

31.

Phase I/II trial of the oral regimen ixazomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma.

Krishnan A, Kapoor P, Palmer JM, Tsai NC, Kumar S, Lonial S, Htut M, Karanes C, Nathwani N, Rosenzweig M, Sahebi F, Somlo G, Duarte L, Sanchez JF, Auclair D, Forman SJ, Berdeja JG.

Leukemia. 2017 Dec 18. doi: 10.1038/leu.2017.352. [Epub ahead of print]

32.

Colo-ovarian fistula.

Rosenzweig M, Marshall J, White RA, Tismenetsky M, Shembde D.

J Surg Case Rep. 2017 Nov 21;2017(11):rjx228. doi: 10.1093/jscr/rjx228. eCollection 2017 Nov.

33.

The Female Self-Advocacy in Cancer Survivorship Scale: A validation study.

Hagan TL, Cohen SM, Rosenzweig MQ, Zorn K, Stone CA, Donovan HS.

J Adv Nurs. 2018 Apr;74(4):976-987. doi: 10.1111/jan.13498. Epub 2017 Dec 11.

34.

Interprofessional Management of Cancer Survivorship: New Models of Care.

Rosenzweig MQ, Kota K, van Londen G.

Semin Oncol Nurs. 2017 Nov;33(4):449-458. doi: 10.1016/j.soncn.2017.08.007. Epub 2017 Sep 21. Review.

PMID:
28943033
35.

Exome-capture RNA sequencing of decade-old breast cancers and matched decalcified bone metastases.

Priedigkeit N, Watters RJ, Lucas PC, Basudan A, Bhargava R, Horne W, Kolls JK, Fang Z, Rosenzweig MQ, Brufsky AM, Weiss KR, Oesterreich S, Lee AV.

JCI Insight. 2017 Sep 7;2(17). pii: 95703. doi: 10.1172/jci.insight.95703. eCollection 2017 Sep 7.

36.

Prevalence and determinants of end-of-life chemotherapy use in patients with metastatic breast cancer.

Mathew A, Achkar T, Abberbock S, Sandhu GS, Jacob ME, Villgran VD, Rosenzweig MQ, Puhalla S, Brufsky AM.

Breast J. 2017 Nov;23(6):718-722. doi: 10.1111/tbj.12905. Epub 2017 Aug 28.

37.

Cognitive and Occupational Function in Survivors of Adolescent Cancer.

Nugent BD, Bender CM, Sereika SM, Tersak JM, Rosenzweig M.

J Adolesc Young Adult Oncol. 2018 Feb;7(1):79-87. doi: 10.1089/jayao.2017.0043. Epub 2017 Aug 7.

38.

Distinct Pattern of Metastases in Patients with Invasive Lobular Carcinoma of the Breast.

Mathew A, Rajagopal PS, Villgran V, Sandhu GS, Jankowitz RC, Jacob M, Rosenzweig M, Oesterreich S, Brufsky A.

Geburtshilfe Frauenheilkd. 2017 Jun;77(6):660-666. doi: 10.1055/s-0043-109374. Epub 2017 Jun 28.

39.

Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling.

Pal SK, Ali SM, Yakirevich E, Geynisman DM, Karam JA, Elvin JA, Frampton GM, Huang X, Lin DI, Rosenzweig M, Lipson D, Stephens PJ, Ross JS, Miller VA, Agarwal N, Shuch B, Choueiri TK, Chung JH.

Eur Urol. 2018 Jan;73(1):71-78. doi: 10.1016/j.eururo.2017.05.033. Epub 2017 Jun 4.

PMID:
28592388
40.

How does the presence of a conspecific individual change the behavioral game that a predator plays with its prey?

Vardi R, Abramsky Z, Kotler BP, Altstein O, Rosenzweig ML.

Oecologia. 2017 Jul;184(3):597-607. doi: 10.1007/s00442-017-3884-6. Epub 2017 May 17.

PMID:
28516320
41.

Preclinical data support leveraging CS1 chimeric antigen receptor T-cell therapy for systemic light chain amyloidosis.

Rosenzweig M, Urak R, Walter M, Lim L, Sanchez JF, Krishnan A, Forman S, Wang X.

Cytotherapy. 2017 Jul;19(7):861-866. doi: 10.1016/j.jcyt.2017.03.077. Epub 2017 May 5.

PMID:
28483281
42.

Current and Emerging Therapies for HER2-Positive Women With Metastatic Breast Cancer.

Porter K, Rosenzweig MQ.

J Adv Pract Oncol. 2017 Mar;8(2):164-168. Epub 2017 Mar 1. Review.

43.

Symptom incidence, distress, cancer-related distress, and adherence to chemotherapy among African American women with breast cancer.

Yee MK, Sereika SM, Bender CM, Brufsky AM, Connolly MC, Rosenzweig MQ.

Cancer. 2017 Jun 1;123(11):2061-2069. doi: 10.1002/cncr.30575. Epub 2017 Feb 15.

44.

Molecular and Electronic Structures of Eight-Coordinate Uranium Bipyridine Complexes: A Rare Example of a Bipy2- Ligand Coordinated to a U4+ Ion.

Rosenzweig MW, Heinemann FW, Maron L, Meyer K.

Inorg Chem. 2017 Mar 6;56(5):2792-2800. doi: 10.1021/acs.inorgchem.6b02954. Epub 2017 Feb 14.

PMID:
28195462
45.

Overcoming nursing barriers to intensive care unit early mobilisation: A quality improvement project.

Hunter OO, George EL, Ren D, Morgan D, Rosenzweig M, Klinefelter Tuite P.

Intensive Crit Care Nurs. 2017 Jun;40:44-50. doi: 10.1016/j.iccn.2016.10.005. Epub 2017 Feb 9.

PMID:
28190550
46.

A cluster randomized trial of a primary palliative care intervention (CONNECT) for patients with advanced cancer: Protocol and key design considerations.

Becker CL, Arnold RM, Park SY, Rosenzweig M, Smith TJ, White DB, Smith KJ, Schenker Y.

Contemp Clin Trials. 2017 Mar;54:98-104. doi: 10.1016/j.cct.2017.01.005. Epub 2017 Jan 16.

47.

Identification of NTRK fusions in pediatric mesenchymal tumors.

Pavlick D, Schrock AB, Malicki D, Stephens PJ, Kuo DJ, Ahn H, Turpin B, Allen JM, Rosenzweig M, Badizadegan K, Ross JS, Miller VA, Wong V, Ali SM.

Pediatr Blood Cancer. 2017 Aug;64(8). doi: 10.1002/pbc.26433. Epub 2017 Jan 18.

PMID:
28097808
48.

Impact of Symptom Clusters on Quality of Life Outcomes in Patients from Japan with Advanced Nonsmall Cell Lung Cancers.

Hamada T, Komatsu H, Rosenzweig MQ, Chohnabayashi N, Nishimura N, Oizumi S, Ren D.

Asia Pac J Oncol Nurs. 2016 Oct-Dec;3(4):370-381. doi: 10.4103/2347-5625.196489.

49.

Perspectives on Self-Advocacy: Comparing Perceived Uses, Benefits, and Drawbacks Among Survivors and Providers

Hagan TH, Rosenzweig M, Zorn K, van Londen J, Donovan H.

Oncol Nurs Forum. 2017 Jan 3;44(1):52-59.

50.

A case of advanced infantile myofibromatosis harboring a novel MYH10-RET fusion.

Rosenzweig M, Ali SM, Wong V, Schrock AB, Laetsch TW, Ahrens W, Heilmann A, Morley S, Chudnovsky Y, Erlich RL, Wang K, Stephens PJ, Ross JS, Miller VA, Oesterheld J.

Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26377. Epub 2016 Dec 28. No abstract available.

PMID:
28028925

Supplemental Content

Loading ...
Support Center